DUKR
DUKE Robotics Corp.
$6.12
+6.25%
$20.9M
No data for this timeframe.
Vol
Market Cap$20.9M
Cap SizeNano Cap
SEC Reports7
Recent Activity
May 18, 2026
SEC
DUKE Robotics Corp. closed an underwritten public offering of 1,125,000 units at $8.20 per unit, each consisting of one
8-K — Impact 7/10
May 18, 2026
SEC
DUKE Robotics Corp. filed a 424B4 prospectus for the resale of 170,954 shares of common stock by selling stockholders. T
424B4 — Impact 4/10
May 18, 2026
SEC
DUKE Robotics Corp. completed a firm-commitment underwritten IPO of 1,125,000 units at $8.20 per unit, each consisting o
424B4 — Impact 6/10
Mar 10, 2026
Insider
Zakai Shlomo sold 10,000 shares
CHIEF FINANCIAL OFFICER @ $0.00 ($0.00)
Mar 10, 2026
Insider
Nachtomy Erez sold 16,000 shares
Director @ $0.00 ($0.00)
Mar 10, 2026
Insider
Balucka Yossef sold 16,000 shares
CHIEF EXECUTIVE OFFICER @ $0.00 ($0.00)
Latest Reports
BULLISH
8-K
7/10
DUKE Robotics Corp. closed an underwritten public offering of 1,125,000 units at $8.20 per unit, each consisting of one
May 18, 2026
NEUTRAL
424B4
4/10
DUKE Robotics Corp. filed a 424B4 prospectus for the resale of 170,954 shares of common stock by selling stockholders. T
May 18, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 10, 2026 | Zakai Shlomo | A | $0.00 |
| Mar 10, 2026 | Nachtomy Erez | A | $0.00 |
| Mar 10, 2026 | Balucka Yossef | A | $0.00 |
| Mar 10, 2026 | Maor Vadim | A | $0.00 |
| Mar 10, 2026 | Golan Keren | A | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
6 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Zakai Shlomo | CHIEF FINANCIAL OFFICER | A | 10,000 | $0.00 | $0.00 |
| Mar 10, 2026 | Nachtomy Erez | Director | A | 16,000 | $0.00 | $0.00 |
| Mar 10, 2026 | Balucka Yossef | CHIEF EXECUTIVE OFFICER | A | 16,000 | $0.00 | $0.00 |
| Mar 10, 2026 | Maor Vadim | CHIEF TECHNOLOGY OFFICER | A | 4,000 | $0.00 | $0.00 |
| Mar 10, 2026 | Golan Keren Gousman | Director | A | 4,000 | $0.00 | $0.00 |
| Mar 10, 2026 | Antebi Eran | Director | A | 4,000 | $0.00 | $0.00 |
7 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 5 neutral. Avg impact: 5.1/10.
BULLISH
8-K
7/10
DUKE Robotics Corp. closed an underwritten public offering of 1,125,000 units at $8.20 per unit, eac
May 18, 2026
NEUTRAL
424B4
4/10
DUKE Robotics Corp. filed a 424B4 prospectus for the resale of 170,954 shares of common stock by sel
May 18, 2026
BEARISH
424B4
6/10
DUKE Robotics Corp. completed a firm-commitment underwritten IPO of 1,125,000 units at $8.20 per uni
May 18, 2026
NEUTRAL
EFFECT
5/10
DUKE Robotics Corp.'s S-1 registration statement (File No. 333-294808) became effective on May 14, 2
May 15, 2026
NEUTRAL
S-1/A
5/10
DUKE Robotics Corp. filed Amendment No. 2 to its S-1 registration statement for a firm-commitment un
May 12, 2026
NEUTRAL
S-1/A
5/10
DUKE Robotics Corp. filed Amendment No. 1 to its S-1 registration statement for a firm-commitment un
Apr 27, 2026
NEUTRAL
8-K
4/10
DUKE Robotics Corp. announced a 25-for-1 reverse stock split effective March 6, 2026, to increase it
Mar 5, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.